Hims & Hers Health Inc (HIMS) is set to release its SEP/2025 earnings performance on 11/03 16:05:00 ET in After Hours trading. Consensus forecasts predict a revenue of 579.85M and an earnings per share (EPS) of 0.09 for the SEP/2025. With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
The company's international revenue growth is a positive indicator, and the transition to branded products with strong retention is promising. However, the negative impact on gross margins due to restructuring costs and the unclear guidance on future margins and EBITDA dampens the outlook. Additionally, while AI and new category investments show potential, they also introduce uncertainty. Given the market cap of $4.3 billion, the stock is likely to experience a neutral movement, as the positive and negative factors balance each other out.
The earnings call reveals strong financial performance with a 50% revenue increase and improved margins. The company turned a net income from a loss, indicating operational improvements. Although risks are acknowledged, the positive financial metrics and strategic initiatives outweigh them. The market cap suggests moderate sensitivity to news, leading to a positive stock price prediction of 2% to 8%.
The earnings call summary reveals strong financial performance with optimistic guidance, including a projected revenue growth of 42% to 47% for Q3 2025 and a robust full-year growth outlook. The company is expanding into new markets and specialties, indicating future growth potential. Despite some uncertainties regarding margin contraction, the overall sentiment remains positive due to strategic investments and international expansion plans. The market cap suggests a moderate reaction, leading to a prediction of a 2% to 8% stock price increase.
Hims & Hers Health Inc (HIMS) is scheduled to release its FY2025Q3 earnings report on Nov 3, 2025, After Hours (approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
Analysts' consensus predicts 579.85M in revenue and an EPS of 0.09 for Hims & Hers Health Inc's FY2025Q3.
Intellectia's exclusive AI algorithms forecast a {conclusion} for Hims & Hers Health Inc's FY2025Q3 earnings, with a prediction date of Nov 3, 2025. Hims & Hers Health Inc {summary}
Leverage Intellectia's AI forecast to position trades ahead of the Nov 3, 2025 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
Predictions are generated two days before a company's earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They're updated in real-time if significant news breaks, ensuring you get fresh insights.
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2025-2026 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
Each prediction includes a detailed rationale, key indicator forecasts, and scenario probabilities to guide your trades. For a *Beat*, consider buying call options or shares; for a *Miss*, explore puts or hedging strategies. The prediction card provides actionable suggestions, like specific option strikes or hedging tips, tailored to your risk tolerance. Trade smart and turn insights into profits!